George A. Mensah MD, FAHA
Director, Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.Dr. George Mensah is a clinician-scientist who currently serves as the Director of the Center for Translation Research and Implementation Science at the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH). In this role, Dr. Mensah leads a trans-NHLBI effort to advance late-stage translational research and implementation science to address gaps in the detection, prevention, treatment, and control of heart, lung, and blood diseases and sleep disorders, and the elimination of related health inequities. His goal is to maximize the health impact of advances made in fundamental discoveries, clinical and translational research, and population science research. Dr. Mensah is an honors graduate of Harvard University. He obtained his medical degree from Washington University and trained in Internal Medicine and Cardiology at Cornell. His professional experience includes more than 20 years of public health service at the U.S. Department of Veterans Affairs, the Centers for Disease Control and Prevention (CDC), and the NIH. In addition to his public service, Dr. Mensah had 15 years of experience in direct patient care, teaching, and research at Cornell, Vanderbilt, and the Medical College of Georgia (MCG). He was a full professor with tenure at MCG and is currently a Visiting Full Professor at the University of Cape Town, South Africa. Dr. Mensah has been admitted to fellowships in several national and international societies including the American Heart Association, American College of Cardiology, and the European Society of Cardiology. He is an Honorary Fellow of the College of Physicians of South Africa and a Life Member of the Association of Black Cardiologists. He maintains active collaboration with several international groups to advance research on the global burden of diseases and risk factors.
Disclosures
No relevant disclosures reported.Recent Contributions to PracticeUpdate:
- Lowering Systolic BP to <120 mm Hg vs <140 mm Hg in Patients at High Cardiovascular Risk With and Without Diabetes or Previous Stroke
- Effects of a Comprehensive Lifestyle Intervention on Cardiovascular Health
- Global Burden of Cardiovascular Diseases and Risk Factors
- Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV